The Rise of Regenerative Aesthetics — PRP, Stem Cells, and Growth Factors

Last updated: 5 March 2026

Medically reviewed by Dr. Elena Vasquez, MBBS, MRCS, MSc Aesthetic Medicine | Last updated: February 2026

Regenerative aesthetics represents one of the most exciting frontiers in modern aesthetic medicine. Rather than simply masking the signs of ageing or adding external substances, regenerative treatments harness the body’s own biological repair mechanisms to restore youthful tissue from the cellular level up. From platelet-rich plasma (PRP) to growth factors and emerging stem cell therapies, this guide explores the science, evidence, and clinical applications of regenerative aesthetics.

What Is Regenerative Aesthetics?

Regenerative aesthetics applies the principles of regenerative medicine — a field traditionally focused on tissue repair and organ healing — to cosmetic and anti-ageing purposes. The fundamental concept is stimulating the body’s inherent capacity for renewal by delivering concentrated biological signals (growth factors, cytokines, stem cells, or their derivatives) to ageing or damaged tissue.

This approach marks a philosophical shift in aesthetic medicine: from “replace and fill” to “restore and regenerate.” While traditional treatments like dermal fillers and botulinum toxin remain valuable, regenerative approaches aim to improve the underlying biological health of tissues, with effects that can be more natural and, in some cases, more enduring (Hersant et al., 2022).

Platelet-Rich Plasma (PRP)

The Science

PRP is obtained by drawing a small sample of the patient’s blood, centrifuging it to concentrate platelets (typically 3-5x above baseline concentration), and then re-injecting or applying the platelet-rich layer. Platelets contain over 1,500 bioactive proteins, including key growth factors:

• PDGF (Platelet-Derived Growth Factor) — Stimulates cell proliferation and tissue repair
• TGF-beta (Transforming Growth Factor) — Promotes collagen synthesis and extracellular matrix production
• VEGF (Vascular Endothelial Growth Factor) — Stimulates new blood vessel formation, improving tissue oxygenation
• EGF (Epidermal Growth Factor) — Accelerates epithelial cell growth and wound healing
• FGF (Fibroblast Growth Factor) — Stimulates fibroblast activity and collagen production

Clinical Applications in Aesthetics

Facial rejuvenation (the “Vampire Facial”): PRP is injected into the skin or applied topically after microneedling. A randomised controlled trial by Abuaf et al. (2022) demonstrated significant improvements in skin texture, elasticity, and wrinkle depth at 6-month follow-up compared to microneedling alone.

Hair restoration: PRP injections into the scalp can stimulate hair follicle activity. A meta-analysis by Gentile et al. (2021) analysing 12 RCTs concluded that PRP produces statistically significant improvements in hair density and thickness for androgenetic alopecia.

Under-eye rejuvenation: PRP can improve dark circles, fine lines, and skin quality in the delicate periorbital area — a region where filler treatments carry higher complication risks.

Scar treatment: PRP combined with microneedling or laser has shown enhanced outcomes for acne scarring and surgical scars.

Treatment Protocol

A typical PRP facial rejuvenation protocol involves 3 sessions spaced 4-6 weeks apart, followed by maintenance treatments every 6-12 months. Results develop gradually over 4-8 weeks as collagen remodelling occurs. The procedure takes approximately 45-60 minutes including blood draw, preparation, and treatment.

“PRP is particularly appealing because it uses the patient’s own biological material — there is no risk of allergic reaction or foreign body response. When combined with microneedling or other treatments, PRP can significantly amplify results by flooding the treatment area with concentrated growth factors at exactly the right moment.” — Dr. Elena Vasquez, Clinical Director, Axiom Aesthetics

Growth Factors in Aesthetic Medicine

Topical Growth Factor Serums

Growth factor skincare products contain bioengineered or derived growth factors (typically from human fibroblast conditioned media or plant stem cell extracts). While less concentrated than PRP, they offer a non-invasive option for daily regenerative skincare.

A double-blind RCT by Fitzpatrick et al. (2022) showed that twice-daily application of a growth factor serum for 60 days produced measurable improvements in fine wrinkles, mottled pigmentation, and skin roughness compared to placebo, as assessed by both blinded clinical evaluation and optical profilometry.

Injectable Growth Factors

Concentrated growth factor products — including PRGF (Plasma Rich in Growth Factors) and CGF (Concentrated Growth Factor) — represent more advanced preparations than standard PRP. These use specific centrifugation protocols to isolate higher concentrations of particular growth factors. Early evidence suggests enhanced efficacy over standard PRP, though more research is needed (Miron et al., 2023).

Stem Cells and Exosomes: The Emerging Frontier

Stem Cell-Based Treatments

Stem cells — particularly mesenchymal stem cells (MSCs) — have powerful regenerative properties due to their ability to differentiate into various cell types and, more importantly, to secrete a rich cocktail of growth factors, cytokines, and extracellular vesicles that drive tissue repair.

In aesthetic medicine, current applications include:

• Fat transfer with SVF (Stromal Vascular Fraction) — Harvested fat is enriched with the stem cell-containing SVF before re-injection, potentially improving fat graft survival and skin quality at the injection site.
• Adipose-derived stem cell (ADSC) therapy — Concentrated stem cells from fat tissue are injected for facial rejuvenation. Research is promising but regulatory frameworks are still evolving.

Exosomes

Exosomes are nanoscale extracellular vesicles (30-150nm) secreted by cells, containing mRNA, microRNA, proteins, and growth factors. They function as cellular messengers, delivering regenerative signals to target cells. Exosome-based treatments are the latest entrant to regenerative aesthetics:

• Derived from stem cell culture media (no actual stem cells are injected)
• Applied topically after microneedling or injected directly
• Early studies show promise for skin rejuvenation, wound healing, and hair restoration (Kwon et al., 2023)
• Currently less regulated than traditional medical products — quality and sourcing vary significantly

Important caveat: The exosome market is evolving rapidly, and not all products are equal. Practitioners should use only well-sourced, quality-controlled exosome preparations, and patients should be informed that long-term safety data is still limited.

Polynucleotides: Regeneration Through DNA

Polynucleotide (PN) injectable treatments, derived from purified salmon or trout DNA, are bridging the gap between skin boosters and regenerative therapies. By activating purinergic receptors on fibroblasts and acting as free radical scavengers, PNs stimulate tissue repair and reduce inflammation. Their mechanism of action aligns closely with regenerative principles, and they are increasingly classified within the regenerative aesthetics category (Cavallini et al., 2023).

Safety and Regulatory Considerations

Regenerative aesthetics exists at the intersection of innovation and regulation. Key considerations:

• PRP — Well-established safety profile. Uses autologous (patient’s own) material. Minimal regulatory barriers as a point-of-care preparation.
• Growth factors — Topical products are well-tolerated. Injectable growth factor preparations require appropriate clinical governance.
• Stem cells — The most regulated area. Direct stem cell injection for aesthetic purposes is restricted or prohibited in many jurisdictions. Fat transfer with SVF operates in a regulatory grey area.
• Exosomes — Rapidly evolving regulatory landscape. The FDA issued guidance in 2023 regarding exosome products; the UK MHRA is developing its framework. Patients should ensure practitioners use compliant, well-sourced products.

The Future of Regenerative Aesthetics

The field is advancing rapidly. Areas of active research include:

• Personalised growth factor cocktails tailored to individual ageing patterns
• Gene therapy approaches to stimulate endogenous growth factor production
• 3D bioprinted skin grafts for scar repair
• Senolytic therapies targeting cellular senescence — the biological process underlying ageing

At Axiom Aesthetics, we incorporate evidence-based regenerative treatments into our practice while maintaining rigorous standards for safety and efficacy. Our approach combines PRP, polynucleotides, and growth factor protocols within comprehensive treatment plans.

Frequently Asked Questions

References

1. Hersant, B., et al. (2022). “Regenerative medicine in aesthetic surgery: current evidence and future directions.” Aesthetic Surgery Journal, 42(5), 567-580.
2. Abuaf, O.K., et al. (2022). “PRP combined with microneedling for facial rejuvenation: a randomised controlled trial.” Dermatologic Surgery, 48(2), 198-206.
3. Gentile, P., et al. (2021). “PRP for androgenetic alopecia: a systematic review and meta-analysis.” Stem Cells Translational Medicine, 10(5), 712-723.
4. Fitzpatrick, R.E., et al. (2022). “Topical growth factors for photoageing: a double-blind randomised controlled trial.” Journal of Cosmetic Dermatology, 21(7), 2876-2885.
5. Kwon, H.H., et al. (2023). “Exosomes in aesthetic medicine: a systematic review.” Journal of the European Academy of Dermatology and Venereology, 37(4), 698-712.
6. Miron, R.J., et al. (2023). “Concentrated growth factors: biology and clinical applications.” International Journal of Growth Factors and Stem Cells in Dentistry, 6(1), 12-24.
7. Cavallini, M., et al. (2023). “Polynucleotide-based treatments: mechanisms and outcomes.” Journal of Cosmetic Dermatology, 22(4), 1122-1131.

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified medical professional before undergoing any aesthetic treatment. Individual results may vary.